Heidelberg Postdoc Symposium / DKTK YAC 2025

Details for Szymon Kmiecik

Title: Dr

Affiliation: Heidelberg University Hospital

Author in the following contribution

• Pharmacological inhibition of the Hsf1 pathway as a potential strategy for treating glioblastoma